AI assistant
VivoSim Labs, INC. — Director's Dealing 2014
Jan 30, 2014
35369_dirs_2014-01-29_3cd61c2a-8c9b-4a8f-a84c-7ade46ef5b97.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORGANOVO HOLDINGS, INC. (ONVO)
CIK: 0001497253
Period of Report: 2014-01-27
Reporting Person: Renard Michael (EVP of Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-27 | Common Stock | M | 10000 | $1.65 | Acquired | 10000 | Direct |
| 2014-01-27 | Common Stock | S | 10000 | $8.92 | Disposed | 0 | Direct |
| 2014-01-29 | Common Stock | M | 30000 | $1.65 | Acquired | 30000 | Direct |
| 2014-01-29 | Common Stock | S | 30000 | $9.9333 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-27 | Stock Option (Right to Buy) | $1.65 | M | 10000 | Disposed | 2022-07-23 | Common Stock (10000) | Direct |
| 2014-01-29 | Stock Option (Right to Buy) | $1.65 | M | 30000 | Disposed | 2022-07-23 | Common Stock (30000) | Direct |
Footnotes
F1: The sale of shares was effecutated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $8.90 to $8.95. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.80 to $10.00. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: This number does not include 660,000 shares of common stock underlying outstanding options held by Mr. Renard; post-transaction Mr. Renard continues to beneficially own or have a right to acquire 660,000 shares of common stock.
F5: 25% of the option shares vest and become exercisable on April 30, 2013 and the remaining shares vest in 12 equal quarterly installments thereafter.